Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

Bibliographic Details
Main Authors: Goepfert, P, Elizaga, M, Montefiori, D, Hural, J, DeRosa, S, Tomaras, G, Seaton, K, Sato, A, Ouedraogo, L, Donastorg, Y, Cardinali, M, Lama, J, Baden, L, Keefer, M, McElrath, J, Kalams, S, Robinson, H
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441271/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441271/

Similar Items